This agenda outlines the IQVIA 360Halo Analysis background, patient-level methodology, core question on DTC-HCP synergy, key results, and statistical takeaways. It highlights DTC (+0.3358%, +59%), HCP (+0.4355%, +55%), and overlap (+0.0499%, +24%) NRx lifts, all >95% confident with implications for combined promotions.
Presentation Agenda
- Background
IQVIA 360Halo Analysis quantifies DTC and HCP promotions individually and together.
- Methodology
1:1 patient-level test vs. control design isolates incremental NRx lift.
- Core Question
Do DTC-exposed patients convert more with HCP campaign-exposed doctors?
- Key Results
DTC +0.3358% (+59%), HCP +0.4355% (+55%), Overlap +0.0499% (+24%) absolute lifts.
- Statistical Significance & Takeaways
All results >95% confidence; key implications for combined promotions. Source: IQVIA 360Halo Analysis